| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.indiaglycols.com | |
| Market Cap | 2,013.12 Cr. | |
| Enterprise Value(EV) | 3,030.40 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 46.87 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 13.87 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 25.93 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 587.48 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 1.11 | Calculated using Price: 650.20 |
| Dividend Yield | 1.15 | Period Ending 2022-03 |
| No. of Shares Subscribed | 3.10 Cr. | 30,961,500 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| India Glycols (IGL), incorporated in 1983, is engaged in the business of manufacturing glycols, ethoxylates and PEGs, performance chemicals, glycol ether and acetates, guar gum and potable alcohol. Promoted by Vam Organics, the company was incorporated under the name as UP Glycols. Since 1989, IGL is the only company in the world that uses renewable agro source based on molasses to manufacture Ethylene Oxide (EO) / Mono Ethylene Glycol (MEG). The company's in-house R&D facility focuses on developing new products and processes. In India, the company is the largest ethoxylate and glycol ether producer thus making it leader in ethylene oxide derivatives/surfactant business. | ||
| 1 Day |
|
-3.34% |
| 1 Week |
|
-6.12% |
| 1 Month |
|
-16.85% |
| 3 Month |
|
-21.61% |
| 6 Month |
|
-26.57% |
| 1 Year |
|
-26.71% |
| 2 Year |
|
+58.55% |
| 5 Year |
|
+42.82% |
| 10 Year |
|
+314.67% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -35.67 | -26.66 | -11.25 | 4.81 | 12.28 | 14.82 | 11.55 | 9.87 | 20.87 | |
| Return on Capital Employed (%) | -2.25 | 1.39 | 2.86 | 9.39 | 15.87 | 20.01 | 13.82 | 9.59 | 16.46 | |
| Return on Assets (%) | -4.98 | -2.75 | -1.68 | 0.99 | 2.83 | 3.71 | 2.92 | 2.64 | 7.06 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 372 | 297 | 718 | 752 | 845 | 963 | 1,034 | 1,169 | 1,792 | 1,820 | |
| Non Curr. Liab. | 829 | 459 | 1,065 | 838 | 911 | 1,097 | 1,068 | 1,183 | 1,110 | 1,069 | |
| Curr. Liab. | 2,083 | 2,399 | 1,836 | 1,902 | 1,665 | 1,725 | 1,984 | 1,768 | 1,749 | 1,921 | |
| Minority Int. | -19 | -22 | |||||||||
| Equity & Liab. | 3,284 | 3,155 | 3,620 | 3,492 | 3,421 | 3,784 | 4,086 | 4,119 | 4,631 | 4,788 | |
| Non Curr. Assets | 1,511 | 1,371 | 2,339 | 2,358 | 2,340 | 2,397 | 2,489 | 2,407 | 3,022 | 3,153 | |
| Curr. Assets | 1,772 | 1,782 | 1,277 | 1,132 | 1,079 | 1,385 | 1,595 | 1,710 | 1,607 | 1,635 | |
| Misc. Exp. not W/O | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | ||
| Total Assets | 3,284 | 3,155 | 3,620 | 3,492 | 3,421 | 3,784 | 4,086 | 4,119 | 4,631 | 4,788 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 2,977 | 2,580 | 2,324 | 2,500 | 3,034 | 3,357 | 3,491 | 2,317 | 2,868 | 6,756 | |
| Other Income | 27 | 58 | 17 | 60 | 131 | 29 | 17 | 21 | 157 | 24 | |
| Total Income | 3,004 | 2,637 | 2,341 | 2,560 | 3,165 | 3,385 | 3,508 | 2,338 | 3,025 | 6,780 | |
| Total Expenditure | -2,775 | -2,456 | -2,146 | -2,310 | -2,813 | -2,945 | -3,156 | -2,052 | -2,745 | -6,491 | |
| PBIDT | 229 | 181 | 195 | 250 | 353 | 440 | 352 | 286 | 280 | 289 | |
| Interest | -159 | -179 | -146 | -133 | -131 | -150 | -100 | -87 | -73 | -82 | |
| Depreciation | -91 | -89 | -69 | -72 | -73 | -76 | -78 | -80 | -80 | -83 | |
| Taxation | 50 | 55 | 24 | -10 | -51 | -81 | -59 | -11 | -39 | 13 | |
| Exceptional Items | -192 | -58 | -61 | 221 | -19 | ||||||
| PAT | -161 | -89 | -57 | 35 | 98 | 134 | 115 | 108 | 309 | 118 | |
| Minority Interest | 3 | ||||||||||
| Share Associate | 0 | 0 | -1 | -1 | 0 | 1 | 21 | 24 | |||
| Other Related Items | |||||||||||
| Consolidated Net Profit | -161 | -89 | -57 | 35 | 97 | 133 | 115 | 132 | 340 | 145 | |
| Adjusted EPS | -52 | -29 | -18 | 11 | 31 | 43 | 37 | 43 | 110 | 47 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 817 | -234 | -171 | 1,231 | 302 | 502 | 147 | 343 | 137 | 116 | |
| Cash Fr. Inv. | -227 | 110 | 175 | -78 | -40 | -103 | -128 | -151 | -148 | 76 | |
| Cash Fr. Finan. | -582 | 87 | -4 | -1,168 | -263 | -399 | 3 | -216 | 11 | -189 | |
| Net Change | 8 | -37 | 0 | -15 | -1 | 0 | 22 | -23 | 0 | 4 | |
| Cash & Cash Eqvt | 60 | 22 | 22 | 6 | 6 | 5 | 27 | 4 | 3 | 7 |
|
Wed, 01 Feb 2023
Board Meeting Intimation for To Inter-Alia Consider And Approve The UnauditedFinancial Results (Standalone & Consolidated) Of The Company For The Quarter AndNine Months Ended 31St December 2022. INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 inter alia to consider and approve the UnauditedFinancial Results (Standalone & Consolidated) of the Company for the quarter andnine months ended 31st December 2022.The information is being hosted on the Companys website at www.indiaglycols.com.Further as intimated vide our letter dated 31st December 2022 pursuant to theCompanys Code of Conduct for Regulating Monitoring and Reporting Trading inSecurities the "Trading Window" for trading in the shares of the Company which hasbeen closed for Designated Persons from Sunday 1st January 2023 shall remainclosed till Friday 10th February 2023 (both days inclusive).This is for your information and records please. |
|
Wed, 01 Feb 2023
Closure of Trading Window Pursuant to Regulation 29 of the Securities and Exchange Board of India (ListingObligations and Disclosure Requirements) Regulations 2015 Notice is hereby giventhat a Meeting of the Board of Directors of the Company will be held onWednesday 8th February 2023 to inter-alia consider and approve the UnauditedFinancial Results (Standalone & Consolidated) of the Company for the quarter andnine months ended 31st December 2022.The information is being hosted on the Companys website at www.indiaglycols.com.Further as intimated vide our letter dated 31st December 2022 pursuant to theCompanys Code of Conduct for Regulating Monitoring and Reporting Trading inSecurities the "Trading Window" for trading in the shares of the Company which hasbeen closed for Designated Persons from Sunday 1st January 2023 shall remainclosed till Friday 10th February 2023 (both days inclusive).This is for your information and records please. |
|
Fri, 27 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to the Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 kindly note that the intimation of loss of Share Certificates have been received from shareholders as per letter attached.In terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022 the Letter of Confirmation(s) in lieu of physical Share Certificates for the above shall be issued after completion of necessary formalities as prescribed.This is for your information and record please. |
| Thu, 02 Feb 2023 |
Close Crossing Last Week Low
|
Close Crossing Last Month Low
|
Closing Below Previous Low
|
Close Within 52 Week Low Zone
|
Close Below Last Week Low
|
Equities
M.F.
Sectors